Technology | Hemodynamic Monitoring Systems | April 01, 2016

Siemens Launches New Version of Sensis Hemodynamic System at ACC 2016

Company’s Sensis Vibe features new, intuitive interface to increase ease of use and efficiency in the cath lab

Siemens, Sensis Vibe hemodynamic system, ACC 2016

April 1, 2016 — Siemens will unveil a revamped version of its established Sensis hemodynamic system at the 65 th Annual Scientific Session and Expo of the American College of Cardiology (ACC), April 2-4 in Chicago. Sensis is the company’s solution for procedural recording and documentation in interventional cardiology and electrophysiology.

Siemens’ brand-new Sensis Vibe offers cath lab employees a reimagined hemodynamic system that masters the rising demand for proficient data management and streamlines documentation and reporting in the interventional environment. With intuitive operation and simplified data entry as well as seamless integration with Siemens’ Artis family of angiography systems, the Sensis Vibe can help facilities document the course of a cath lab procedure for follow-up care and administrative processes.

Several new features distinguish Sensis Vibe from previous Siemens hemodynamic systems. FlashDoc, the system’s redesigned approach to procedure data documentation, targets optimal ease of use and includes three core components that are embedded in a new, intuitive user interface. The QuickAdd component is a new interaction concept that searches the system database for matching entries as soon as the user begins typing. The result is auto-completion that allows staff members to remain focused on the patient while completing necessary administrative tasks. The CaseLog component, which enables the physician to follow the entire course of a procedure at a glance, is a time-stamped overview of all hemodynamic/electrical events and other occurrences recorded or manually captured. CaseLog’s structural data lines, customized display and filter options enable staff to adapt this overview to their preferences. And Smart SIS, the new version of the Sensis Information System, helps staff verify data entries and measurements automatically in addition to highlighting inconsistencies even before a staff member closes a study. In this way, Smart SIS helps to ensure creation of a complete, consistent report.

Sensis Vibe facilitates adoption of a hemodynamic recording and documentation system in the cardiovascular hybrid operating room (OR) with the new HemoBox signal input unit. With a hygienic surface design, flexible mounting options and improved cable management, the OR-compliant HemoBox provides physicians with patient vital signs and intracardiac measurements. With HemoBox, the heart team can rely on the same recording and documentation capabilities whether they deliver care and treatment in the hybrid OR or the cath lab.

Watch the VIDEO “Trends in Cardiac Technology on the Show Floor at ACC.16.” MDbuyline clinical analyst Tom Watson, BS, RCVT, explains the new technology trends in hemodynamic systems and the need to integrated into the electronic medical record.  

For more information: www.siemens.com

Related Content

A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes according to a late-breaking study at ACC 2018.
News | ACC | March 20, 2018
March 20, 2018 — The anti-inflammatory...
Dabigatran Reduces Major Cardiovascular Complications in Patients With Myocardial Injury after Noncardiac Surgery
News | ACC | March 20, 2018
March 20, 2018 — Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart att
Statins May Bring Benefits at Time of Treatment for Heart Attack, Angina

Image from presentation, "Statins Evaluation in Coronary Procedures and Revascularization," Berwanger 

News | ACC | March 20, 2018
March 20, 2018 — Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broa
Overlay Init